Neogap Therapeutics receives EMA’s ATMP classification for its personalised cancer cell therapy CSP Neogap Therapeutics receives EMA’s ATMP classification for its personalised cancer cell therapy creativebharatgroup@gmail.com December 10, 2024 Neogap Therapeutics AB, a Swedish clinical-stage biotechnology company, announces that the European Medicines... Read More Read more about Neogap Therapeutics receives EMA’s ATMP classification for its personalised cancer cell therapy
